Relación entre biometría fetal, producto de acumulación de los lípidos y condición trófica al nacer / Relationship between fetal biometry, lipid accumulation product and the trophic condition at birth

Fundamento: Las alteraciones del estado nutricional materno generalmente se relacionan con desviaciones del crecimiento fetal, que pueden detectarse por los parámetros biofísicos fetales e identifican la posible condición trófica al nacer. Objetivo: Determinar la posible relación entre los parámetros biométricos fetales, la condición trófica al nacer y el producto de acumulación de los lípidos. Metodología: Se realizó un estudio transversal en el Policlínico Chiqui Gómez Lubian del municipio Santa Clara, durante el año 2019, en una población de 253 gestantes normopeso supuestamente sanas al inicio de la gestación. La muestra no probabilística fue de 144 gestantes. Las variables de estudio fueron: producto de acumulación de los lípidos, biometría fetal y condición trófica al nacer. Se utilizaron métodos teóricos, empíricos y estadísticos. Resultados: En el segundo trimestre ningún parámetro biométrico coincidió con la condición al nacer de pequeño, mientras que para el grande coincidieron las circunferencias cefálica y abdominal. En el tercer trimestre la longitud del fémur y la circunferencia abdominal coinciden en la identificación del pequeño y del grande. El PAL se correlacionó con la circunferencia abdominal del tercer trimestre y con el peso al nacer; presentando mayor frecuencia de valores en el tercer tertil para los nacimientos grandes. Conclusiones: La circunferencia abdominal fue el parámetro biométrico con mayor coincidencia con la condición trófica al nacer, la que se asoció con valores en el tercer tertil del PAL para la detección de nacimientos grandes, relacionándose el fenotipo normopeso metabólicamente obeso con el crecimiento fetal por exceso.

Background: Maternal nutritional status disorders are usually related to fetal growth deviations, which can be detected by fetal biophysical parameters and identify the possible trophic condition at birth. Objective: To determine the possible relationship between fetal biometric parameters, the birth trophic state and lipid accumulation product. Methodology: A cross-sectional study was conducted at the Chiqui Gómez Lubian Polyclinic in Santa Clara municipality, during 2019, in a population of 253 normal-weight pregnant women who were apparently healthy at the beginning of their gestation. The non-probability sample was made up of 144 pregnant women. Study variables were: lipid accumulation product, fetal biometry and trophic condition at birth. Theoretical, empirical and statistical methods were used. Results: In the second trimester, none of the biometric parameters matched the condition at birth as a small child, while in the large one the head and abdominal circumferences matched. In the third trimester, femoral length and abdominal circumference coincide in identifying the small one and the large one. LAP correlated with third trimester abdominal circumference and birth weight, presenting higher frequency of values in the third tertile for large births. Conclusions: Abdominal circumference was the biometric parameter with the highest coincidence with trophic condition at birth, associated with values in the third tertile of the LAP for detecting large births, relating the metabolically obese normal weight phenotype with excessive fetal growth.

The effect of probiotics on serum lipid levels in non-obese healthy adults with hyperlipidemia: a systematic review and meta-analysis of randomized controlled trials / El efecto de los probióticos sobre los niveles de lípidos séricos en adultos sanos no obesos con hiperlipidemia: revisión sistemática y metaanálisis de ensayos controlados y aleatorizados

Introduction: probiotics might have a potential effect to manage serum lipid levels as nutraceuticals. Objective: this systematic review was conducted to explore whether probiotics have an efficient result in non-obese healthy adults with hyperlipidemia. Methods: PubMed, Embase, the Cochrane Central Register of Controlled Trials, and Web of Science were searched for randomized controlled trials (from their commencement to January 2021). This meta-analysis was performed by Review Manager 5.3 and STATA 15.1. Changes in serum lipid levels after the intervention were used to evaluate the effect of the probiotics, which were expressed as the weighted mean difference (WMD) with a 95 % confidence interval (CI). Results: a total of 16 studies, which could be regarded as 21 independent trials with 1429 participants, were included in this meta-analysis following our inclusion criteria. It could be observed that probiotics could significantly lower total cholesterol (TC) (WMD: -0.34 mmol/L, 95 % CI: -0.45 to -0.23 mmol/L; p < 0.001, I2 = 73.9 %) and low-density lipoprotein cholesterol (LDL-C) (WMD: -0.26 mmol/L, 95 % CI: -0.36 to -0.17 mmol/L; p < 0.001, I2 = 79.0 %) levels in non-obese healthy adults with hyperlipidemia, while no significant effect between the probiotic intervention and control groups was observed on high-density lipoprotein cholesterol (HDL-C) (WMD: 0.00 mmol/L, 95 % CI: -0.02 to 0.02 mmol/L; p = 0.001, I2 = 56.6 %) and triglyceride (TG) (WMD: -0.08 mmol/L, 95 % CI: -0.18 to 0.01 mmol/L; p = 0.003, I2 = 52.4 %) levels. Conclusion: this systematic review showed that probiotics may provide a promising way to reduce serum lipid levels in non-obese healthy adults with hyperlipidemia, but their specific effect still needs more clinical experiments to be proven (AU)

Introducción: los probióticos podrían tener efecto para controlar los niveles de lípidos séricos como nutracéuticos. Objetivo: esta revisión sistemática se realizó para explorar si los probióticos tienen un resultado eficiente en adultos sanos no obesos con hiperlipidemia. Métodos: se realizaron búsquedas de ensayos controlados aleatorios en PubMed, Embase, el Registro Cochrane Central de Ensayos Controlados y Web of Science (desde su inicio hasta enero de 2021). Este metanálisis fue realizado mediante Review Manager 5.3 y STATA 15.1. Los cambios de los niveles de lípidos séricos después de la intervención se utilizaron para evaluar el efecto de los probióticos, que se expresaron como la diferencia de medias ponderada (DMP) con un intervalo de confianza (IC) del 95 %. Resultados: en este metaanálisis se incluyeron un total de 16 estudios, que podrían considerarse 21 ensayos independientes con 1429 participantes, siguiendo nuestros criterios de inclusión. Se pudo observar que los probióticos podían reducir significativamente el colesterol total (CT) (DMP: -0,34 mmol/L, IC del 95 %: -0,45 a -0,23 mmol/L; p < 0,001, I2 = 73,9 %) y el colesterol de lipoproteínas de baja densidad (C-LDL) (DMP: -0,26 mmol/L, IC del 95 %: -0,36 a -0,17 mmol/L; p < 0,001, I2 = 79,0 %) en los adultos sanos no obesos con hiperlipidemia, mientras que no hubo efectos significativos entre los grupos de intervención y de control en el colesterol de lipoproteínas de alta densidad (HDL-C) (DMP: 0,00 mmol/L, IC del 95 %: -0,02 a 0,02 mmol/L; p = 0,001, I2 = 56,6 %) y los triglicéridos (TG) (DMP: -0,08 mmol/L, IC del 95 %: -0,18 a 0,01 mmol/L; p = 0,003, I2 = 52,4 %). Conclusión: esta revisión sistemática manifestó que los probióticos podrían suponer una forma prometedora de reducir los niveles de lípidos séricos en los adultos sanos no obesos con hiperlipidemia, pero se necesitan más experimentos clínicos para demostrar su efecto específico (AU)

The effect of probiotics on the serum lipid levels in non-obese healthy adults with hyperlipidemia: A systematic review and meta-analysis of randomized controlled trials.

INTRODUCTION: Introduction: probiotics might have a potential effect to manage serum lipid levels as nutraceuticals. Objective: this systematic review was conducted to explore whether probiotics have an efficient result in non-obese healthy adults with hyperlipidemia. Methods: PubMed, Embase, the Cochrane Central Register of Controlled Trials, and Web of Science were searched for randomized controlled trials (from their commencement to January 2021). This meta-analysis was performed by Review Manager 5.3 and STATA 15.1. Changes in serum lipid levels after the intervention were used to evaluate the effect of the probiotics, which were expressed as the weighted mean difference (WMD) with a 95 % confidence interval (CI). Results: a total of 16 studies, which could be regarded as 21 independent trials with 1429 participants, were included in this meta-analysis following our inclusion criteria. It could be observed that probiotics could significantly lower total cholesterol (TC) (WMD: -0.34 mmol/L, 95 % CI: -0.45 to -0.23 mmol/L; p < 0.001, I2 = 73.9 %) and low-density lipoprotein cholesterol (LDL-C) (WMD: -0.26 mmol/L, 95 % CI: -0.36 to -0.17 mmol/L; p < 0.001, I2 = 79.0 %) levels in non-obese healthy adults with hyperlipidemia, while no significant effect between the probiotic intervention and control groups was observed on high-density lipoprotein cholesterol (HDL-C) (WMD: 0.00 mmol/L, 95 % CI: -0.02 to 0.02 mmol/L; p = 0.001, I2 = 56.6 %) and triglyceride (TG) (WMD: -0.08 mmol/L, 95 % CI: -0.18 to 0.01 mmol/L; p = 0.003, I2 = 52.4 %) levels. Conclusion: this systematic review showed that probiotics may provide a promising way to reduce serum lipid levels in non-obese healthy adults with hyperlipidemia, but their specific effect still needs more clinical experiments to be proven.

INTRODUCCIÓN: Introducción: los probióticos podrían tener efecto para controlar los niveles de lípidos séricos como nutracéuticos. Objetivo: esta revisión sistemática se realizó para explorar si los probióticos tienen un resultado eficiente en adultos sanos no obesos con hiperlipidemia. Métodos: se realizaron búsquedas de ensayos controlados aleatorios en PubMed, Embase, el Registro Cochrane Central de Ensayos Controlados y Web of Science (desde su inicio hasta enero de 2021). Este metanálisis fue realizado mediante Review Manager 5.3 y STATA 15.1. Los cambios de los niveles de lípidos séricos después de la intervención se utilizaron para evaluar el efecto de los probióticos, que se expresaron como la diferencia de medias ponderada (DMP) con un intervalo de confianza (IC) del 95 %. Resultados: en este metaanálisis se incluyeron un total de 16 estudios, que podrían considerarse 21 ensayos independientes con 1429 participantes, siguiendo nuestros criterios de inclusión. Se pudo observar que los probióticos podían reducir significativamente el colesterol total (CT) (DMP: -0,34 mmol/L, IC del 95 %: -0,45 a -0,23 mmol/L; p < 0,001, I2 = 73,9 %) y el colesterol de lipoproteínas de baja densidad (C-LDL) (DMP: -0,26 mmol/L, IC del 95 %: -0,36 a -0,17 mmol/L; p < 0,001, I2 = 79,0 %) en los adultos sanos no obesos con hiperlipidemia, mientras que no hubo efectos significativos entre los grupos de intervención y de control en el colesterol de lipoproteínas de alta densidad (HDL-C) (DMP: 0,00 mmol/L, IC del 95 %: -0,02 a 0,02 mmol/L; p = 0,001, I2 = 56,6 %) y los triglicéridos (TG) (DMP: -0,08 mmol/L, IC del 95 %: -0,18 a 0,01 mmol/L; p = 0,003, I2 = 52,4 %). Conclusión: esta revisión sistemática manifestó que los probióticos podrían suponer una forma prometedora de reducir los niveles de lípidos séricos en los adultos sanos no obesos con hiperlipidemia, pero se necesitan más experimentos clínicos para demostrar su efecto específico.

[Diagnostic accuracy of the tri-ponderal mass index in identifying the unhealthy metabolic obese phenotype in obese patients]. / Precisión diagnóstica del índice de masa triponderal (kg/m3) para identificar el fenotipo de riesgo metabólico en pacientes obesos.

INTRODUCTION: The metabolically healthy obese (MHO) phenotype defines obese patients who have preserved insulin sensitivity and absence of metabolic complications. This phenotype is associated with a lower risk of cardiovascular disease and type2 diabetes in adulthood. OBJECTIVES: To determine the prevalence of MHO and the metabolically unhealthy obesity (MUO) phenotype in a cohort of obese children and adolescents and to establish the predictive capacity of the tri-ponderal mass index (TMI) and other anthropometric parameters in order to identify these patients. PATIENTS AND METHODS: A cross-sectional study was conducted on 239 obese patients (125males) from 8 to 18years of age. Grade3 obesity was present in 45.9% of the patients. ROC curves were used to find the best cut-off point for: TMI, body mass index (BMI), BMI z-score (BMIzs), and waist/height index (WHI). MHO components: plasma blood glucose, plasma triglycerides, HDL-cholesterol, and blood pressure. RESULTS: The prevalence of MUO in the study cohort was 62.4%. No differences between genders were observed, and it was increasing with the age and obesity degree. The TMI has a sensitivity of 75.8 and a specificity of 42.2 to identify the MUO patients. The best cut-off point for TMI is 18.7kg/m3, for BMI it was 30.4kg/m2, for BMIzs +3.5SD, and 0.62 for WHI. CONCLUSIONS: The diagnostic accuracy of TMI in identifying obese adolescents with metabolic risk was similar to BMI and WHI. However, the TMI is much simpler to use and simplifies the categorization of the obesity in both genders.

Prevalence and characteristics of the metabolically healthy obese phenotype in children and adolescents in a Mexican state.

OBJECTIVES: To determine the prevalence of the Metabolically Healthy Obesity (MHO), and Metabolically Obese Normal-Weight (MONW) phenotypes in a sample of children and adolescents. To evaluate which clinical and laboratory variables are related to the MONW and MHO phenotypes. METHODS: A cross-sectional study was carried out in children and adolescents aged 6-18 years old, presumably healthy. Somatometry, glucose, insulin, triglycerides, HDL-cholesterol, LDL-cholesterol, HOMA-IR, triglycerides/HDL ratio, triglycerides and glucose index, and leptin/adiponectin, were determined. RESULTS: Data from 620 children and adolescents were included (50.65% were males); the median age was 11 years. The prevalence of the MONW phenotype was 22.85% (95%CI 16.85%-29.79%), and the MHO phenotype 27.61% (95%CI 22.60%-33.06%). The variables that significantly explained the possibility of presenting the MONW and MHO phenotype were triglycerides/HDL ratio, and product of triglycerides and glucose. Insulin and HOMA-IR were significantly associated with the MHO phenotype but not with the MONW phenotype. CONCLUSIONS: Prevalence of metabolically healthy obese phenotype is lower in the Mexican population compared to European studies; thus, future studies should determine if this difference relies upon genetic profile or lifestyle. The indices to assess the action of insulin based on lipids can help identify children and adolescents with the MHO and MONW phenotypes.

Are young Iranian women with metabolically healthy obesity at increased risk of CVD incidence? / Jovens iranianas obesas metabolicamente saudáveis têm maior risco de incidência de DCV?

Abstract Background The association between the Metabolically Healthy Obese (MHO) phenotype in the absence of metabolic syndrome and subsequent cardiovascular disease remains unclear. Objectives We examined the association between MHO and CVD risk in young Iranian women. Methods We studied 183 women aged 20-35 years from a population of 308 candidates. We classified participants into 4 phenotypes. We measured body composition, blood pressure, and biochemical factors in all participants. Results The Metabolically Healthy Normal Weight (MHNW) and Normal Weight Obese (NWO) phenotypes had no statistical differences in any biochemistry variables. FBS, TG, LDL/HDL, Cholesterol/HDL, hs-CRP, and atherogenic index of plasma (AIP) were all higher in Metabolically Unhealthy Obese (MUO) than MHO individuals, whereas HDL was higher in MHO than in MUO individuals. LDL/HDL and hs-CRP were higher in MHO participants than MHNW participants, whereas HDL-c was higher in MHNW than MHO. Conclusions Results of the present study demonstrate that young women displaying the MHO phenotype have a favorable metabolic profile as shown by lower FBS, TG, LDL-c/HDL, Cho/HDL, hs-CRP, and AIP and higher HDL levels than the MUO phenotype. However, MHO individuals were still at greater risk of CVD incidence (lower HDL and higher hs-CRP levels) than MHNW individuals.

Resumo Contexto A associação entre o fenótipo obeso metabolicamente saudável (OMS) na ausência de síndrome metabólica e doença cardiovascular subsequente permanece incerta. Objetivos Examinamos a associação entre o fenótipo OMS e risco de DCV em jovens iranianas. Métodos Analisamos 183 mulheres com idade de 20-35 anos de uma população de 308 candidatas. Classificamos as participantes em quatro fenótipos. Mensuramos composição corporal, pressão arterial e fatores bioquímicos em todas as participantes. Resultados Os fenótipos com peso normal metabolicamente saudável (PNMS) e obeso com peso normal não apresentaram diferenças estatísticas em nenhuma das variáveis bioquímicas. Os níveis de glicemia sanguínea em jejum (GSJ), triglicerídeos (TG), relação LDL/HDL, HDL, proteína C reativa ultrassensível (PCR-us) e índice aterogênico do plasma (IAP) foram mais elevados em obesas metabolicamente não saudáveis (OMNS) do que em indivíduos OMSs, enquanto o HDL foi maior em OMSs do que em indivíduos OMNSs. A relação LDL/HDL e o nível de PCR-us foram mais elevados em participantes OMSs do que em participantes com PNMS, enquanto o HDL foi maior naquelas com PNMS do que nas OMSs. Conclusões Os resultados do presente estudo demonstram que mulheres jovens com o fenótipo OMS têm um perfil metabólico favorável, conforme demonstrado pelos níveis menores de GSJ, TG, relação LDL/HDL, HDL, PCR-us e IAP e pelos níveis maiores de HDL em comparação às mulheres com o fenótipo OMNS. Entretanto, indivíduos OMSs ainda apresentavam maior risco de DCV incidente (níveis menores de HDL e maiores de PCR-us) do que indivíduos com PNMS.

Aspectos nutricionales del paciente obeso crítico / Nutritional aspects of critical obese patient

El paciente obeso supone un desafío nutricional en la Unidad de Cuidado Intensivos, tanto por el manejo metabólico, como por la dificultad para nutrirlo correctamente. Es común pensar que el obeso crítico no corre riesgo de desnutrición; sin embargo, puede desnutrirse fácilmente durante la internación. La obesidad visceral es un factor independiente de muerte en la Unidad de Cuidados Intensivos. A su vez, el síndrome metabólico y la sarcopenia, antecedentes habituales del obeso, aumentan el riesgo de resultados adversos. Como consecuencia de la sobrealimentación, las complicaciones metabólicas más frecuentes suelen ser: hiperglucemia, hipertrigliceridemia, hipercapnia y esteatosis hepática. En cambio, una reducción en el aporte calórico podría aumentar la sensibilidad a la insulina y prevenir dichas complicaciones. El catabolismo proteico y la pérdida de masa muscular son más importantes en el paciente obeso crítico que en aquel con peso normal, debido a que utiliza una mayor proporción de proteínas como sustrato energético. Por tal motivo, se recomienda una alimentación hipocalórica e hiperproteica para estos pacientes durante su enfermedad crítica. (AU)

Obese patients represent a nutritional challenge in the Intensive Care Unit, due to the difficulties in maintaining an adequate metabolic and nutritional support. It is often thought that obese critically ill patients have no nutritional risk; however, they may easily become undernourished during their hospitalization. Visceral fat is an independent risk factor for mortality in the Intensive Care Unit. Besides, metabolic syndrome and sarcopenia usually detected in the obese patient, may increase adverse outcomes. Most common overfeeding metabolic consequences are: hyperglycemia, hypertriglyceridemia, hypercapnia, and liver steatosis. However, a reduced calorie delivery may improve insulin sensitivity and prevent such complications. Protein catabolism and muscle loss are greater in obese critically ill patients than in lean patients, because they use a higher proportion of proteins as energy substrates. Hence, a low-calorie and high-protein diet is recommended for these patients during their critical illness.(AU)

Super obese patient undergoing minimally invasive mitral repair: perioperative management

Obesity is an epidemic health issue showing increasing numbers all over the world. In the United States one third of adults are obese and 10 percent of health cost is related to obesity. Airway management, vascular access and positioning can be more challenging. Anaesthesiologists need to be prepared to the particular challenges these patients pose in cardiac rooms. Minimally invasive cardiac surgery (MICS) is an alternative to perform cardiac surgical procedures that has been related to decreased rate of infection and lower transfusion rates. This case report outlines the perioperative anesthetic management of a super obese patient undergoing a minimally invasive mitral valve repair.

La obesidad es una problema epidémico de salud que ha aumentado en el mundo. En los Estados Unidos, un tercio de los pacientes adultos son obesos y un 10 por ciento del costo de salud es asociado a la obesidad. Los anestesistas necesitan estar preparados para los retos particulares que tiene estos pacientes en los pabellones cardiacos. La cirugía cardiaca mínimamente invasiva es una alternativa para realizar los procedimientos cardiacos con menor tasa de infección y transfusiones. Este reporte de caso describe el manejo anestésicos perioperatorio de un paciente super obeso para una cirugía mínimamente invasiva de la válvula mitral.

Abordagem do segmento superior do corpo em pacientes ex-obesos com cirurgia única: toracobraquio-mamoplastia / Unique surgery for the upper body segment in patients with massive weight loss: thoracobrachio-mammoplasty

INTRODUÇÃO Os pacientes ex-obesos necessitam de uma abordagem complexa, diante do grande excesso de pele decorrente da perda ponderal. Em alguns casos, muitas cirurgias plásticas são necessárias, não havendo uma padronização na associação destas cirurgias. No segmento superior do corpo, a região dos braços, a lateral do tórax e as mamas normalmente são acometidas, principalmente nas mulheres. Diversas técnicas foram desenvolvidas com o objetivo de alcançar resultados melhores e com cicatrizes mais escondidas. Algumas técnicas podem ser associadas, sendo realizadas em um único tempo cirúrgico. Quando a equipe é bem estruturada, o tempo cirúrgico é reduzido, significando mais segurança para o paciente. MÉTODO: Os autores apresentam uma técnica que oferece padronização no tratamento do ex-obeso, que é realizada em tempo único: a Mamoplastia (pela técnica de Pitanguy ou com aposição de prótese mamária), a Toracoplastia (com a retirada do excesso de pele na lateral do tórax) e a Braquioplastia (realizada com um desenho retilíneo na parte mais inferior dos braços). RESULTADOS: Os sete casos foram avaliados quanto ao tempo cirúrgico, à localização das cicatrizes, à forma final e à simetria. Entre as complicações, houve deiscências parciais (14%) e cicatrizes hipertróficas (14%). O resultado estético foi satisfatório para os pacientes em 84% dos casos, sendo que a qualidade da cicatrização do paciente, queloide ou cicatrizes hipercrômicas, foi a maior causa de insatisfação. CONCLUSÃO: A utilização da técnica de Toracobraquio-mamoplastia em um único tempo se mostrou efetiva no tratamento do ex-obeso, oferecendo mais uma opção, diante das outras cirurgias que estes pacientes normalmente necessitam.

INTRODUCTION Ex-obese patients require a complex surgical approach because of the large amount of excess skin due to their massive weight loss. In some cases, several plastic surgeries are needed, and there is no existing standard in the coordination of these surgeries. In the upper segment of the body, the arms, side of the thorax, and breasts are usually affected, mainly in women. Several techniques have been developed with the aim of achieving better results with better hidden scars. Some techniques may be associated, being carried out in a single surgical procedure. A well-structured surgical team leads to a reduced surgical time, which means higher safety for the patient. METHOD: We present a technique for standardization in the treatment of ex-obese patients that is performed in a single step, comprising mammoplasty (according to Pitanguy's technique or with placement of breast prosthesis), thoracoplasty (with the removal of excess skin on the side of the chest), and brachioplasty (performed with a rectilinear drawing at the lowest part of the arms). RESULTS: Seven cases were evaluated in terms of surgical time, location of the scars, and final shape and symmetry. The complications included partial dehiscence (14%) and hypertrophic scars (14%). The aesthetic result was satisfactory for 84% of the patients; on the other hand, the quality of cicatrization, keloid, and hypertrophic scars were the major causes of dissatisfaction. CONCLUSION: The use of the thoracobrachio-mammoplasty technique in a single surgical time was effective in the treatment of ex-obese patients, offering yet another option among other surgeries that these patients usually need.

Obeso metabólicamente normal / Metabolically healthy obese patients

Introducción: La obesidad es un problema de Salud Pública que tiende a incrementarse y que compromete la salud de las personas. Objetivos: Conocer la prevalencia de obesos metabólicamente normales (OMN) en función de la presencia de factores de riesgo cardiovascular en una población adulta que presenta obesidad y obesidad mórbida. Diseño: Estudio observacional, descriptivo y de corte transversal. Lugar: Servicio de Endocrinología, Hospital Dos de Mayo, Lima. Perú. Participantes: Personas adultas sin enfermedades metabólicas. Intervenciones: En el período abril de 2009 a mayo de 2010, se estudió a todas aquellas personas adultas que consultaron por obesidad y que dijeron no tener diabetes mellitus tipo 2, hipertensión arterial y dislipidemias. Se les pesó, talló y se midió su circunferencia de cintura (CC). Con las dos primeras se calculó el índice de masa corporal y quienes tenían 30 kg/m2 o más ingresaron al estudio. Se les midió insulina, glucosa y perfil lipídico. Con la glucosa, c-HDL, triglicéridos y la CC se determinó el síndrome metabólico y con la insulina y la glucosa, el modelo homeostático de evaluación de la resistencia en insulina (HOMA-IR), con la finalidad de identificar resistencia a la insulina (RI). Se dividió el grupo en dos: obesos de 30 a 39,9 kg/m2 y 40 kg/m2 y más. El análisis estadístico se efectuó con las pruebas de t-student y de chi-cuadrado, con un intervalo de confianza de 95 por ciento y nivel de significancia <0,05. Principales medidas de resultados: Promedio y desviación estándar de las variables estudiadas y prevalencia de OMN y OMnoN. Resultados: La población estudiada alcanzó a 158 personas, de las cuales 91,2 por ciento correspondió al género femenino. Entre las diferencias entre los dos grupos OMN y OMnoN, referente a las variables antropométricas y bioquímicas tuvieron significación estadística el peso, talla, CC, insulina y el HOMA-IR. La prevalencia de OMN, de acuerdo a Wildman, fue 7 por ciento en el total de obesos y...

Introduction: Obesity is a public health problem that tends to increase and compromises the health of the people. Objectives: To determine the prevalence of metabolically normal obese (OMN) subjects depending on the presence of cardiovascular risk factors in an adult population showing obesity and morbid obesity. Design: Observational, descriptive and cross-section study. Setting: Department of Endocrinology, Hospital Dos de Mayo, Lima, Peru. Participants: Obese adults without metabolic diseases. Interventions: The study was conducted during the period between April 2009 and May 2010 in all adults consulting for obesity and who declared not having type 2 diabetes mellitus, arterial hypertension or dyslipidemia. Weight, height and waist circumference (WC) were obtained, and body mass index (BMI) was calculated. Those who had 30 kg/m2 or more were included in the study. Insulin, glucose and lipid profile were determined. Metabolic syndrome was determined through measurement of glucose, HDL-C, triglycerides and WC. Insulin resistance (IR) was diagnosed by glucose and insulin resistance homeostasis model assessment (HOMA-IR). Two groups were distinguished: obese with BMI of 30 to 39.9 kg/m2, and obese with BMI of 40 kg/m2 and more. Statistical analysis was performed using student t test and chi-square with a 95 per cent confidence interval and a significance level of <0.05. Main outcome measures: Average and standard deviation variables; prevalence of OMN and OMnotN. Results: From the 158 subjects, 91.2 per cent were female. The OMN and OMnotN groups showed statistically significant difference in weight, height, WC, insulin and HOMA-IR. OMN prevalence bt Wildman criteria was 7 per cent in all obese and 7.3 and 6.4 per cent in the OMN and OMnotN groups, while by Meiggs criteria it was 13 per cent, 15.5 and 2.1 per cent respectively. Conclusions: By the criteria used the study showed the presence of a reduced number of obese subjects considered OMN...

Are there healthy obese?

It is currently postulated that not all obese individuals have to be considered as pathological subjects. From 10% to 20% of obese people studied do not show the metabolic changes common in obese patients. The term "healthy obese" has been coined to refer to these patients and differentiate them from the larger and more common group of pathological obese subjects. However, the definition of "healthy obese" is not clear. Use of "healthy obese" as a synonym for obese without metabolic complications is risky. Clinical markers such as insulin resistance are used to identify this pathology. It is not clear that healthy obese subjects have lower morbidity and mortality than pathologically obese patients. According to some authors, healthy obese would represent an early stage in evolution towards pathological obesity. There is no agreement as to the need to treat healthy obese subjects.

Cirurgia plástica pós-gastroplastia: perfil das deficiências nutricionais com implicações na cicatrização / Plastic surgery after gastroplasty: nutritional deficiency profile with wound-healing implications

INTRODUÇÃO: Os cirurgiões plásticos têm recebido em seus consultórios e ambulatórios um número cada vez maior de pacientes com queixa de deformidade do contorno corporal após maciças perdas ponderais secundárias a cirurgias bariátricas. Todavia, em função das restrições alimentares e disabsorções cirúrgicas, são frequentes complicações metabólicas e distúrbios nutricionais no pós-operatório tardio das gastroplastias. O objetivo deste estudo é detectar a prevalência dos principais distúrbios nutricionais relacionados à cicatrização em pacientes de ambulatório especializado em cirurgia plástica do paciente pós-gastroplastia. MÉTODO: é um estudo observacional, transversal e descritivo, em que os pacientes foram avaliados clinicamente e através de protocolo laboratorial. RESULTADOS: foram avaliados 32 pacientes com gastroplastia há pelo menos dois anos e estabilidade ponderal há no mínimo seis meses. Os principais distúrbios detectados foram: anemia (56% dos pacientes), com carências na bioquímica do ferro (31,2%) e da vitamina B12 (25%), bem como deficiências dos íons zinco (18,7%) e cobre (3,1%). Houve carências discretas no perfil proteico e ausência de déficits na bioquímica básica e lipidograma. CONCLUSÃO: é dever do cirurgião plástico conhecer a fundo a prevalência dos principais distúrbios nutricionais relacionados à cicatrização na população de pacientes pós-gastroplastia no sentido de corrigir eventuais carências e prevenir complicações. Sabe-se, contudo, que ainda são necessários mais estudos para correlacionar qualquer deficiência alimentar às intercorrências observadas no pós-operatório deste grupo de pacientes.

INTRODUCTION: Plastic surgeons have received in their outpatient clinics an increasing number of patients complaining of body contour defects due to the massive weight loss after a bariatric surgery. However, owing to dietary restrictions and surgical desorption, metabolic complications and nutritional disorders are commonly observed in the late postoperative period after gastroplasty. The aim of this study was to determine the prevalence of major nutritional disorders related to healing in patients at a specialized outpatient plastic surgery clinic who underwent gastroplasty. METHOD: This is an observational, transversal, and descriptive study, in which a laboratory protocol was used to clinically evaluate and assess the patients. RESULTS: Thirty-two patients who underwent gastroplasty at least 2 years previously with weight stability for at least 6 months were evaluated. The major disorders identified included anemia (56% of patients) and deficiency in iron (31.2%), vitamin B12 (25%), zinc ions (18.7%), and copper (3.1%). Mild deficiencies in the protein profile were also observed; however, no deficiencies in basic and lipid biochemistry were noted. CONCLUSION: The plastic surgeon should have an in-depth knowledge about the prevalence of the major nutritional disorders related to healing in postbariatric patients, to allow correction of possible deficiencies and prevention of complications. However, more studies would be required to correlate any dietary deficiency to the complications observed in the postoperative period in this group of patients.

Sistematização e conduta do serviço de cirurgia plástica do hospital geral de Goiânia em mamoplastia pós perda ponderal nos últimos dez anos / Sistematizacion and conduct of plastic surgery service of hospital geral de goiânia in mammoplasty in massive weight loss patients in last ten years

With the increase of the population obesity indices occurred a growth of the numbers of ex-obese patients and aesthetic/reconstructive plastic surgery in this population. Objectives: To present a systematic approach adopted in patients undergoing breast surgery after massive weight loss at Hospital Geral de Goiânia (HGG) in the last 10 years, and assess the results. Method: We conducted a retrospective studyof cases of breast surgery after massive weight loss in the Department of Plastic Surgery of HGG, from January 2002 to December 2011. The patients were individually analyzed preoperatively and submitted to the classification of Kaluf to breast dysmorphism after major weight loss. The operative technique varied depending on the classification of the type of breast. Results: The sample totaled 73 female patients, with mean age of 44 years and mean weight loss of 48 kg. In 41 patients (56.16%) was used the technique with inclusion of prostheses and in 32 (43.83 %) chose to not include silicone implants. Complications occurred in eight patients (10.95%), one case of hematoma (1.36%), two cases of suffering partial nipple-areola complex (2.73%), five cases of small suture dehiscence or delayed healing(6.84%) and one case of breast ptosis in the immediate postoperative period (1.36%). Conclusion: Due to the wide range of dimorphisms in emaciat- ed patients, in particular changes in their breasts, we note that it is necessary to establish protocols and routines for effective assessment and treatment, with the least possible morbidity, associated with better cosmetic...

Com o aumento dos índices de obesidade populacional ocorreu um crescimento do número de pacientes ex-obesos, e de cirurgias plásticas nesta população. Objetivos: Apresentar a sistematização e conduta adotada nos pacientes submetidos a mamoplastia, após grande perda ponderal, operados no Hospital Geral de Goiânia (HGG) nos últimos 10 anos, bem como avaliar os resultados obtidos. Método: Foi realizado um estudo retrospectivo dos casos de mamoplastia após grande perda ponderal, operados no Serviço de Cirurgia Plástica do HGG, de janeiro de 2002 a dezembro de 2011. As pacientes foram analisadas individualmente no pré-operatório e submetidas à classificação de Kaluf, para dismorfias mamárias após grande emagrecimento. A técnica operatória variou em função da classificação do tipo de mama. Resultados: A casuística totalizou 73 pacientes, do sexo feminino, com faixa etária média de 44 anos, e perda ponderal média de 48 Kg. Em 41 pacientes (56,16%) foi utilizada a técnica com inclusão de próteses, e em 32(43,83%) optou-se por não incluir os implantes de silicone. As complicações ocorreram em oito pacientes (10,95%), sendo um caso de hematoma (1,36%), dois casos de sofrimento parcial do complexo aréolo-mamilar (2,73%), cinco casos de pequenas deiscências de sutura ou retardo de cicatrização (6,84%) e um caso de ptose de mama no pós-operatório imediato (1,36%). Conclusão: Devido à grande variação de dismorfismos em pacientes emagrecidos, em especial as alterações mamárias, notamos que se torna necessário o estabelecimento de protocolos e rotinas para avaliações e tratamentos eficazes, com a menor morbimortalidade possível, associados aos melhores resultados estéticos...

Plaqueta e leptina em adolescentes com obesidade / Platelet and leptin in obese adolescents

OBJETIVOS: Analisar a influência de obesidade na contagem de células imunológicas e na concentração dos hormônios cortisol e leptina, a fim de estabelecer uma relação entre as variáveis analisadas. MÉTODOS: Foram recrutados 27 adolescentes obesos [índice de massa corporal (IMC) ≥ percentil 95[ e 21 não-obesos (IMC ≤ percentil 75), de ambos os sexos, com idade entre 15 e 19 anos, na fase pós-púbere. O IMC foi calculado através da divisão do peso pela altura ao quadrado e a composição corporal foi estimada por pletismografia no sistema Bod PodTM. Amostras de sangue foram colhidas para análise de leucócitos, neutrófilos, linfócitos, monócitos, plaquetas, cortisol e leptina. O teste de Kolmogorov-Smirnov foi utilizado, seguido pelo teste t de Student independente supondo distribuição normal. O nível de significância estabelecido foi p < 0,05 e expresso como média ± desvio padrão. Os dados foram analisados utilizando o programa SPSS para Windows versão 12.0. RESULTADOS: Não houve diferença entre o grupo obeso e o não-obeso na concentração sérica de leucócitos, neutrófilos, linfócitos, monócitos e cortisol. O grupo de adolescentes obesos apresentou maiores concentrações de plaquetas e leptina (p < 0,01). A prevalência de hiperleptinemia foi de 25,92 por cento nos adolescentes obesos (15,38 por cento, sexo masculino e 35,7 por cento, feminino). CONCLUSÕES: Os adolescentes obesos apresentaram maiores concentrações de plaquetas e leptina em comparação aos não-obesos. Observou-se que as adolescentes obesas apresentaram maior prevalência de hiperleptinemia do que os adolescentes obesos.

OBJECTIVE: To analyze the influence of obesity status on immune cell count and concentration of the hormones cortisol and leptin, in order to establish a relationship among the variables analyzed. METHODS: We recruited 27 obese [body mass index (BMI) ≥ 95th percentile[ and 21 non-obese (BMI ≤ 75th percentile) adolescent boys and girls, aged 15-19 years at the post-pubertal stage. BMI was calculated as body weight divided by height squared, and body composition was estimated by plethysmography in the Bod PodTM system. Blood samples were collected to analyze leukocytes, neutrophils, lymphocytes, monocytes, platelets, cortisol, and leptin. The Kolmogorov-Smirnov test was performed, followed by the independent Student t test in case of normal distribution. Significance values were set at p < 0.05 and expressed as means ± standard deviation. The statistical package SPSS for Windows version 12.0 was used. RESULTS: There was no difference between obese and non-obese adolescents in terms of leukocyte, neutrophil, lymphocyte, monocyte and cortisol serum concentrations. The group of obese adolescents presented higher platelet and leptin concentrations (p < 0.01). The prevalence of hyperleptinemia was 25.92 percent in the obese adolescents (15.38 percent in boys and 35.7 percent in girls). CONCLUSIONS: Obese adolescents have higher platelet and leptin concentrations in comparison with non-obese adolescents. It was also found that obese girls presented a higher prevalence of hyperleptinemia than obese boys.